Autoimmune hepatitis is an independent risk factor for allograft loss and morbidity after liver transplantation: evidence from the Swiss Transplant Cohort Study
Swiss Medical Weekly · 2026-11-16 · 156 (11) · 5375
DOI: 10.57187/5375 ↗At a glance
Kohortenstudie in Swiss Medical Weekly, published online on 2026-11-16. Written by Aurélie Rosat and 22 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
BACKGROUND: Liver transplantation is the only curative option for end-stage autoimmune hepatitis (AIH). Although overall outcomes are favourable, previous studies suggest an increased risk of allograft loss and mortality in this population. We assessed post-liver transplantation outcomes in AIH recipients using data from the nationwide multicentre Swiss Transplant Cohort Study (STCS). METHODS: We included all adult patients undergoing a first liver transplantation between May 2008 and December 2020. Indications were categorised as AIH, alcohol-related liver disease, viral liver disease, primary biliary cholangitis, primary sclerosing cholangitis, metabolic dysfunction-associated liver disease or other/mixed aetiologies. Survival analyses and multivariable competing risk Cox models were applied. Clinical Registration number (CER-VD): 2021-01982. RESULTS: Among 880 liver transplantation recipients, 23 (2.6%) underwent liver transplantation for AIH. The 1-, 5- and 10-year post-liver transplantation survival rates in the AIH group were 87.0%, 76.5% and 76.5%, respectively – comparable to other indications. Allograft failure occurred in 34.8% of AIH recipients, significantly more often than in alcohol-related liver disease (8.3%, p
Cite
APA
Rosat, A., Beretta-Piccoli, B. T., Hoessly, L. D., Stampf, S., Koller, M., Goossens, N., Magini, G., Compagnon, P., Fraga, M., Kolev, M., Semmo, N., Berzigotti, A., Banz, V., Müllhaupt, B., Kremer, A., Oberholzer, J., Semela, D., Heim, M. H., Brunner, S., …, & Study, T. S. T. C. (2026). Autoimmune hepatitis is an independent risk factor for allograft loss and morbidity after liver transplantation: evidence from the Swiss Transplant Cohort Study. Swiss Medical Weekly, 156(11), 5375. https://doi.org/10.57187/5375
Vancouver
Rosat A, Beretta-Piccoli BT, Hoessly LD, Stampf S, Koller M, Goossens N, et al. Autoimmune hepatitis is an independent risk factor for allograft loss and morbidity after liver transplantation: evidence from the Swiss Transplant Cohort Study. Swiss Medical Weekly. 2026;156(11):5375. doi:10.57187/5375
BibTeX
@article{Rosat2026,
author = {Rosat, Aurélie and Beretta-Piccoli, Benedetta Terziroli and Hoessly, Linard D. and Stampf, Susanne and Koller, Michael and Goossens, Nicolas and Magini, Giulia and Compagnon, Philippe and Fraga, Montserrat and Kolev, Mirjam and Semmo, Nasser and Berzigotti, Annalisa and Banz, Vanessa and Müllhaupt, Beat and Kremer, Andreas and Oberholzer, Jose and Semela, David and Heim, Markus H. and Brunner, Simon and Pascual, Manuel and Moradpour, Darius and Vionnet, Julien and Study, the Swiss Transplant Cohort},
title = {Autoimmune hepatitis is an independent risk factor for allograft loss and morbidity after liver transplantation: evidence from the Swiss Transplant Cohort Study},
journal = {Swiss Medical Weekly},
year = {2026},
volume = {156},
number = {11},
pages = {5375},
doi = {10.57187/5375}
}
EUVIMED